BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6206536)

  • 21. [Zaditen: a pharmacologic and therapeutic profile].
    Craps LP
    Allerg Immunol (Paris); 1988 Dec; 20(10):369-71. PubMed ID: 2463842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastric mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer.
    Karmeli F; Eliakim R; Okon E; Rachmilewitz D
    Gastroenterology; 1991 May; 100(5 Pt 1):1206-16. PubMed ID: 1707383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ketotifene: experimental and clinical data].
    Craps L
    Schweiz Med Wochenschr; 1980 Feb; 110(6):187-91. PubMed ID: 6769157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug prevention of bronchial asthma: inhibition of histamine and exercise-induced asthma by a new anti-anaphylactic oral preparation (ketotifen) (author's transl)].
    Wüthrich B; Radielovic P
    Dtsch Med Wochenschr; 1978 Nov; 103(47):1865-9. PubMed ID: 30613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of food on the bronchial response in adult asthmatic patients, and the protective role of ketotifen.
    Furlan J; Suskovic S; Rus A
    Allergol Immunopathol (Madr); 1987; 15(2):73-81. PubMed ID: 3618443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effect of DS-4574 on leukotriene- or antigen-induced bronchoconstriction in guinea pigs.
    Aibara S; Mori M; Tsukada W
    Int Arch Allergy Immunol; 1993; 100(3):268-73. PubMed ID: 7680929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of ketotifen on the eicosanoid system, immunoreactivity and bronchial patency in patients with obstructive pulmonary diseases].
    Efimov VV; Blazhko VI; Liashenko MM; Voeĭkova LS; Bondar' TN
    Ter Arkh; 1991; 63(3):70-3. PubMed ID: 1648274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological rehabilitation of the asthmatic child.
    Debelić M
    Allergol Immunopathol (Madr); 1981; Suppl 9():99-102. PubMed ID: 6819777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mediators of the allergic reaction. Slow reacting substance (SRS-A)].
    Naranjo P
    Allergol Immunopathol (Madr); 1975; 3(4):239-54. PubMed ID: 5879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The possible effect of a ketotifen preparation on beta-receptor blockade].
    Kosturkov G; Markov M; Vŭlcheva T; Popov T
    Vutr Boles; 1989; 28(2):19-22. PubMed ID: 2569788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulphidopeptide leukotrienes in asthma.
    Lee TH; O'Hickey SP; Jacques C; Hawksworth RJ; Arm JP; Christie P; Spur BW; Crea AE
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():415-9. PubMed ID: 1847780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of thiols on the immunologic release of slow reacting substance of anaphylaxis. II. Other in vitro and in vivo models.
    Orange RP; Moore EG
    J Immunol; 1976 Feb; 116(2):392-7. PubMed ID: 55439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathophysiology of bronchial asthma].
    Elsasser S; Perruchoud AP
    Schweiz Rundsch Med Prax; 1992 Nov; 81(45):1346-9. PubMed ID: 1279775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukotrienes and prostaglandins in asthma.
    Bisgaard H
    Allergy; 1984 Aug; 39(6):413-20. PubMed ID: 6208802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of chemical mediator release from human leukocytes and lung in vitro by a novel antiallergic agent, KB-2413.
    Nishimura N; Ito K; Tomioka H; Yoshida S
    Immunopharmacol Immunotoxicol; 1987; 9(4):511-21. PubMed ID: 2449488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiallergy activity of Sch 37224, a new inhibitor of leukotriene formation.
    Kreutner W; Sherwood J; Sehring S; Rizzo C; Chapman RW; Siegel MI; Egan RW
    J Pharmacol Exp Ther; 1988 Dec; 247(3):997-1003. PubMed ID: 2462630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ketotifen, disodium cromoglycate, and verapamil inhibit leukotriene activity: determination by tube leukocyte adherence inhibition assay.
    Fink A; Bibi H; Eliraz A; Schlesinger M; Bentwich Z
    Ann Allergy; 1986 Aug; 57(2):103-6. PubMed ID: 3090908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inhibition of anaphylactic chemical mediator release by tranilast].
    Yamamura H; Kohno SW; Ohata K; Koda A; Kawai M; Horiba M
    Arerugi; 1987 Oct; 36(10):937-42. PubMed ID: 2450531
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of primate bronchoalveolar mast cells. I. IgE-dependent release of histamine, leukotrienes, and prostaglandins.
    Wells E; Harper ST; Jackson CG; Mann J; Eady RP
    J Immunol; 1986 Dec; 137(12):3933-40. PubMed ID: 2431048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.